These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7380041)

  • 21. Panel discussion: Environmental sampling in an aseptic environment. III. Cross contamination control.
    Elias WF
    Bull Parenter Drug Assoc; 1974; 28(6):263-9. PubMed ID: 4455322
    [No Abstract]   [Full Text] [Related]  

  • 22. Quality control of absolute bacteria removal filters.
    Pall DB
    Bull Parenter Drug Assoc; 1975; 29(4):192-204. PubMed ID: 1131463
    [No Abstract]   [Full Text] [Related]  

  • 23. [A device for filtering sterile drug solutions].
    Khrapovitskiĭ KI; Berezniuk MA
    Voen Med Zh; 1990 Nov; (11):58-9. PubMed ID: 2077722
    [No Abstract]   [Full Text] [Related]  

  • 24. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association.
    J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cleaning of machines for pharmaceutical production: microbiological investigation to establish validation procedures].
    Anastasio P; Carazzone M; Genova R; Malesani L; Molinari ML
    Boll Chim Farm; 1987 Mar; 126(3):116-20. PubMed ID: 3689577
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of drug production technology on the transition of cesium-137 to liquid drug form].
    Antonova VA; Seditskaia ZL
    Gig Sanit; 1989 Jul; (7):87-8. PubMed ID: 2529188
    [No Abstract]   [Full Text] [Related]  

  • 27. Development and validation of analytical procedure--control of residual 2-iodopropane in latanoprost.
    Groman A; Stolarczyk EU
    Acta Pol Pharm; 2010; 67(6):673-6. PubMed ID: 21229885
    [No Abstract]   [Full Text] [Related]  

  • 28. [Flow of laminar air: use in sterile rooms].
    Lumini E
    Boll Chim Farm; 1975 Jul; 114(7):361-74. PubMed ID: 1164445
    [No Abstract]   [Full Text] [Related]  

  • 29. [The microbiologic quality of an oral preparation as the result of proper formulation and technological design].
    Anastasio P; Carazzone M; Pongiluppi S
    Boll Chim Farm; 1988; 127(11-12):245-8. PubMed ID: 3254250
    [No Abstract]   [Full Text] [Related]  

  • 30. Validation and routine operation of a sterile dry powder filling facility.
    Prout G
    J Parenter Sci Technol; 1982; 36(5):199-204. PubMed ID: 6927748
    [No Abstract]   [Full Text] [Related]  

  • 31. Filling vials aseptically while monitoring for bacterial contamination.
    Dirksen JW; Larsen RV
    Am J Hosp Pharm; 1975 Oct; 32(10):1031-2. PubMed ID: 1190216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An approach to establishing parenteral solution sterilization cycles.
    Korczynski MS; Peterson CL; Loshbaugh CC
    Bull Parenter Drug Assoc; 1974; 28(6):270-7. PubMed ID: 4455323
    [No Abstract]   [Full Text] [Related]  

  • 33. Quality-control plan for intravenous admixture programs. I: Visual inspection of solutions and environmental testing.
    Morris BG; Avis KE
    Am J Hosp Pharm; 1980 Feb; 37(2):189-95. PubMed ID: 7361790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aseptic work under various hygienic conditions.
    Aslund B; Olson OT; Sandell E
    Acta Pharm Suec; 1977; 14(5-6):517-24. PubMed ID: 596167
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies on the production technic of water honey pills].
    Xu JM
    Zhong Yao Tong Bao; 1985 Jun; 10(6):26-8. PubMed ID: 2934169
    [No Abstract]   [Full Text] [Related]  

  • 36. Control of particle contamination of solutions for pharmaceutical use: selection of a suitable method.
    Lotteau P
    J Parenter Sci Technol; 1990; 44(6):302-5. PubMed ID: 2277317
    [No Abstract]   [Full Text] [Related]  

  • 37. [Purity requirements for drugs].
    Battaglino G
    Ann Ist Super Sanita; 1982; 18(4):615-20. PubMed ID: 7188516
    [No Abstract]   [Full Text] [Related]  

  • 38. PDA letter to the FDA regarding process simulation testing.
    Fry EM
    PDA J Pharm Sci Technol; 2001; 55(3):145-9. PubMed ID: 11417104
    [No Abstract]   [Full Text] [Related]  

  • 39. [Mechanical device for the washing of pharmaceutical bottles].
    Petrishchev IP; Nedel'ko VV
    Farmatsiia; 1971; 20(2):61-2. PubMed ID: 5562917
    [No Abstract]   [Full Text] [Related]  

  • 40. Future development of harmonized guidelines.
    Hayakawa T
    Dev Biol Stand; 1996; 88():331-2. PubMed ID: 9119158
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.